Hrain Biotechnology Co., Ltd.

Quick facts

Phase 2 pipeline

• Human BCMA Targeted T Cells Injection · Oncology
  BCMA-targeted T cells

Phase 1 pipeline

• Human CD19-CD22 Targeted T Cells Injection
• Immune inhibitors

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Hrain Biotechnology Co., Ltd. portfolio CI brief
• Hrain Biotechnology Co., Ltd. pipeline updates RSS